Fusion Pharmaceuticals Inc.
NASDAQ:FUSN
21.55 (USD) • At close June 3, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 61.925 | 43.861 | 52.898 | 90.517 | 65.344 | 28.768 |
| Short Term Investments
| 172.153 | 127.013 | 147.897 | 131.882 | 0 | 0 |
| Cash and Short Term Investments
| 234.078 | 186.635 | 200.795 | 222.399 | 65.344 | 28.768 |
| Net Receivables
| 4.215 | 1.723 | 0.357 | 0.794 | 0.428 | 0.483 |
| Inventory
| 0 | -9.869 | 10.377 | 4.244 | 0.503 | 0.835 |
| Other Current Assets
| 5.102 | 0.509 | 0.233 | 0.727 | 0.278 | 0.15 |
| Total Current Assets
| 243.395 | 178.998 | 211.762 | 228.164 | 66.553 | 30.236 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 23.896 | 10.315 | 9.453 | 1.967 | 1.272 | 1.104 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| -0.849 | 0 | 0 | 0 | -1.497 | 0 |
| Long Term Investments
| 14.584 | 15.761 | 19.987 | 77.082 | 1.497 | 0 |
| Tax Assets
| 3.961 | 4.806 | 1.645 | 0.653 | 0.078 | 0.019 |
| Other Non-Current Assets
| 0.849 | 9.184 | 9.424 | 2.81 | 1.497 | 0.032 |
| Total Non-Current Assets
| 42.441 | 40.066 | 40.509 | 82.512 | 2.847 | 1.155 |
| Total Assets
| 285.836 | 219.064 | 252.271 | 310.676 | 69.4 | 31.391 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 1.86 | 2.686 | 2.195 | 3.399 | 0.83 | 0.349 |
| Short Term Debt
| 4.163 | 1.443 | 1.215 | 0 | 0 | 0 |
| Tax Payables
| 0.301 | 0.299 | 0.297 | 2.799 | 0.117 | 0.059 |
| Deferred Revenue
| 0.333 | 0.924 | 1.538 | 1 | 0 | 0 |
| Other Current Liabilities
| 9.864 | 10.014 | 7.563 | 7.458 | 3.443 | 1.25 |
| Total Current Liabilities
| 16.22 | 15.067 | 12.511 | 11.857 | 4.273 | 1.599 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 34.775 | 38.81 | 5.507 | 0 | 5.741 | 0 |
| Deferred Revenue Non-Current
| 0.667 | 2.667 | 2.5 | 4 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 11.393 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0.301 | 0.299 | 0.297 | 0.306 | 92.874 | 47.709 |
| Total Non-Current Liabilities
| 47.136 | 41.776 | 8.304 | 4.306 | 98.615 | 47.709 |
| Total Liabilities
| 63.356 | 56.843 | 20.815 | 16.163 | 102.888 | 49.308 |
| Equity: | ||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 71.592 | 0 |
| Common Stock
| 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings
| -376.759 | -281.862 | -194.25 | -113.203 | -34.774 | -18.585 |
| Accumulated Other Comprehensive Income/Loss
| 0.237 | -0.469 | -0.115 | 0.044 | 0 | -0.138 |
| Other Total Stockholders Equity
| 599.002 | 444.552 | 425.821 | 407.672 | -70.306 | 0.806 |
| Total Shareholders Equity
| 222.48 | 162.221 | 231.456 | 294.513 | -33.488 | -17.917 |
| Total Equity
| 222.48 | 162.221 | 231.456 | 605.189 | -12.527 | -17.917 |
| Total Liabilities & Shareholders Equity
| 285.836 | 219.064 | 252.271 | 310.676 | 69.4 | 31.391 |